Although there is no consensus on the optimal serum 25(OH)D concentration or parathyroid hormone targets in patients with secondary hyperparathyroidism, recent evidence suggests that 25(OH)D levels > 50 ng/mL are required to effectively reduce parathyroid hormone levels [18]. This evidence concerns the gene PTH and secondary hyperparathyroidism.